Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
|Articles|May 16, 2023
Are You Attending the 2023 APA Annual Meeting?
Author(s)Psychiatric Times Editors
Let us know if you're attending!
Advertisement
Are you attending the 2023 APA Annual Meeting in San Francisco?
We want to know what you think! We invite readers to share brief abstracts and comments on sessions they have attended for publication consideration. Email us at
Stay up to date with everything APA by following us on
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Treating PTSD Among Veterans at Risk for Suicide
2
FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder
3
Podcast: Not Always Panic. A Cardiologist and Psychiatrist on Reading a Racing Heart
4
Positive Phase 1b Results Demonstrate Clinical Proof-of-Concept for ALKS 7290 in Adults With ADHD
5